• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

掌握变异:方差分量与个性化医疗

Mastering variation: variance components and personalised medicine.

作者信息

Senn Stephen

机构信息

Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.

出版信息

Stat Med. 2016 Mar 30;35(7):966-77. doi: 10.1002/sim.6739. Epub 2015 Sep 28.

DOI:10.1002/sim.6739
PMID:26415869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5054923/
Abstract

Various sources of variation in observed response in clinical trials and clinical practice are considered, and ways in which the corresponding components of variation might be estimated are discussed. Although the issues have been generally well-covered in the statistical literature, they seem to be poorly understood in the medical literature and even the statistical literature occasionally shows some confusion. To increase understanding and communication, some simple graphical approaches to illustrating issues are proposed. It is also suggested that reducing variation in medical practice might make as big a contribution to improving health outcome as personalising its delivery according to the patient. It is concluded that the common belief that there is a strong personal element in response to treatment is not based on sound statistical evidence.

摘要

本文考虑了临床试验和临床实践中观察到的反应存在的各种变异来源,并讨论了估计相应变异成分的方法。尽管这些问题在统计文献中通常已有充分阐述,但在医学文献中似乎理解不足,甚至统计文献偶尔也会出现一些混淆。为了增进理解和交流,本文提出了一些简单的图形方法来说明这些问题。本文还指出,减少医疗实践中的变异可能对改善健康结果做出与根据患者情况个性化治疗同样大的贡献。本文得出结论,认为治疗反应中存在强烈个人因素的普遍观点并非基于可靠的统计证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/2c6764bb7524/SIM-35-966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/448c1727a123/SIM-35-966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/9457a9f01022/SIM-35-966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/e170c46e62ef/SIM-35-966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/682aa3ed10a2/SIM-35-966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/2c6764bb7524/SIM-35-966-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/448c1727a123/SIM-35-966-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/9457a9f01022/SIM-35-966-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/e170c46e62ef/SIM-35-966-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/682aa3ed10a2/SIM-35-966-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e101/5054923/2c6764bb7524/SIM-35-966-g005.jpg

相似文献

1
Mastering variation: variance components and personalised medicine.掌握变异:方差分量与个性化医疗
Stat Med. 2016 Mar 30;35(7):966-77. doi: 10.1002/sim.6739. Epub 2015 Sep 28.
2
Personalized treatment selection using data from crossover designs with carry-over effects.使用具有残留效应的交叉设计数据进行个性化治疗选择。
Stat Med. 2019 Dec 10;38(28):5391-5412. doi: 10.1002/sim.8372. Epub 2019 Oct 21.
3
Subgroup analysis with semiparametric models toward precision medicine.亚组分析与精准医学的半参数模型。
Stat Med. 2018 May 20;37(11):1830-1845. doi: 10.1002/sim.7638. Epub 2018 Mar 25.
4
Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.利用试点数据确定双臂随机试验的规模,以找到近乎最优的个性化治疗策略。
Stat Med. 2016 Apr 15;35(8):1245-56. doi: 10.1002/sim.6783. Epub 2015 Oct 28.
5
Biomarker threshold adaptive designs for survival endpoints.用于生存终点的生物标志物阈值适应性设计。
J Biopharm Stat. 2018;28(6):1038-1054. doi: 10.1080/10543406.2018.1434191. Epub 2018 Feb 13.
6
The benefit of stratification in clinical trials revisited.重新审视临床试验分层的益处。
Stat Med. 2011 Oct 30;30(24):2881-9. doi: 10.1002/sim.4351. Epub 2011 Sep 8.
7
Analysis of Poisson frequency data under a simple crossover trial.简单交叉试验下泊松频率数据的分析
Stat Methods Med Res. 2016 Feb;25(1):385-99. doi: 10.1177/0962280212455753. Epub 2012 Aug 16.
8
A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials.关于交叉临床试验分析中相关误差的一般线性模型中误设定的说明。
PLoS One. 2019 Mar 14;14(3):e0213436. doi: 10.1371/journal.pone.0213436. eCollection 2019.
9
Some methods for heterogeneous treatment effect estimation in high dimensions.一些在高维中进行异质处理效应估计的方法。
Stat Med. 2018 May 20;37(11):1767-1787. doi: 10.1002/sim.7623. Epub 2018 Mar 6.
10
Enhanced precision in the analysis of randomized trials with ordinal outcomes.对具有有序结局的随机试验进行分析时提高精度。
Biometrics. 2016 Jun;72(2):422-31. doi: 10.1111/biom.12450. Epub 2015 Nov 17.

引用本文的文献

1
Continuous glucose monitor overestimates glycemia, with the magnitude of bias varying by postprandial test and individual - a randomized crossover trial.持续葡萄糖监测高估血糖水平,偏差幅度因餐后测试和个体而异——一项随机交叉试验。
Am J Clin Nutr. 2025 May;121(5):1025-1034. doi: 10.1016/j.ajcnut.2025.02.024. Epub 2025 Feb 26.
2
Inter-individual differences in the blood pressure lowering effects of dietary nitrate: a randomised double-blind placebo-controlled replicate crossover trial.膳食硝酸盐降压效果的个体差异:一项随机双盲安慰剂对照重复交叉试验。
Eur J Nutr. 2025 Feb 24;64(2):101. doi: 10.1007/s00394-025-03616-x.
3

本文引用的文献

1
Personalized medicine: Time for one-person trials.个性化医疗:单人试验的时代。
Nature. 2015 Apr 30;520(7549):609-11. doi: 10.1038/520609a.
2
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.癌症免疫疗法。一种树突状细胞疫苗可增加黑色素瘤新抗原特异性T细胞的广度和多样性。
Science. 2015 May 15;348(6236):803-8. doi: 10.1126/science.aaa3828. Epub 2015 Apr 2.
3
Bounds on sufficient-cause interaction.充分原因相互作用的界。
Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease.
在评估阿尔茨海默病治疗的临床益处时避免因果欺诈。
Alzheimers Dement. 2025 Feb;21(2):e14457. doi: 10.1002/alz.14457. Epub 2025 Jan 27.
4
Individual Responses to Repeated Dosing with Anthocyanin-Rich New Zealand Blackcurrant Extract During High-Intensity Intermittent Treadmill Running in Active Males.在活跃男性进行高强度间歇跑步机跑步期间,对富含花青素的新西兰黑加仑提取物重复给药的个体反应。
Nutrients. 2024 Dec 10;16(24):4253. doi: 10.3390/nu16244253.
5
Towards Precision Sports Nutrition for Endurance Athletes: A Scoping Review of Application of Omics and Wearables Technologies.面向耐力运动员的精准运动营养:组学和可穿戴技术应用的范围综述。
Nutrients. 2024 Nov 19;16(22):3943. doi: 10.3390/nu16223943.
6
A replicate crossover trial on the interindividual variability of sleep indices in response to acute exercise undertaken by healthy men.一项关于健康男性急性运动后睡眠指标个体间变异性的重复交叉试验。
Sleep. 2025 Mar 11;48(3). doi: 10.1093/sleep/zsae250.
7
Exploratory analysis of the variable response to an intensive lifestyle change program for metabolic syndrome.对代谢综合征强化生活方式改变计划的可变反应的探索性分析。
BMC Prim Care. 2024 Oct 1;25(1):357. doi: 10.1186/s12875-024-02608-w.
8
Metabolic Predictors of Cardiorespiratory Fitness Responsiveness to Continuous Endurance and High-Intensity Interval Training Programs: The TIMES Study-A Randomized Controlled Trial.心肺适能对持续耐力训练和高强度间歇训练计划反应的代谢预测因素:TIMES研究——一项随机对照试验
Metabolites. 2024 Sep 23;14(9):512. doi: 10.3390/metabo14090512.
9
Do all individuals benefit equally from non-surgical periodontal therapy? Secondary analyses of systematic review data.所有个体从非手术牙周治疗中获得的益处都相同吗?系统评价数据的二次分析。
J Periodontal Res. 2024 Sep 25. doi: 10.1111/jre.13347.
10
Are there interindividual differences in the reactive hypoglycaemia response to breakfast? A replicate crossover trial.早餐后反应性低血糖的个体间差异?一项复制交叉试验。
Eur J Nutr. 2024 Dec;63(8):2897-2909. doi: 10.1007/s00394-024-03467-y. Epub 2024 Sep 4.
Eur J Epidemiol. 2014 Nov;29(11):813-20. doi: 10.1007/s10654-014-9953-9. Epub 2014 Sep 24.
4
A note regarding 'random effects'.关于“随机效应”的说明。
Stat Med. 2014 Jul 20;33(16):2876-7. doi: 10.1002/sim.5965.
5
Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?个性化医疗、疾病预防与逆医疗法则:弊大于利?
Eur J Epidemiol. 2014 Jun;29(6):383-90. doi: 10.1007/s10654-014-9898-z. Epub 2014 Apr 12.
6
Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice.流行病学、表观遗传学与“黯淡前景”:在人群健康研究与实践中接受随机性
Int J Epidemiol. 2011 Jun;40(3):537-62. doi: 10.1093/ije/dyr117.
7
How Intermountain trimmed health care costs through robust quality improvement efforts.通过强有力的质量改进措施来降低成本。
Health Aff (Millwood). 2011 Jun;30(6):1185-91. doi: 10.1377/hlthaff.2011.0358. Epub 2011 May 19.
8
Time to tackle unwarranted variations in practice.是时候解决医疗实践中不必要的差异了。
BMJ. 2011 Mar 17;342:d1513. doi: 10.1136/bmj.d1513.
9
Investigating variability in patient response to treatment--a case study from a replicate cross-over study.探究患者对治疗反应的变异性——一项复制交叉研究的案例研究。
Stat Methods Med Res. 2011 Dec;20(6):657-66. doi: 10.1177/0962280210379174. Epub 2010 Aug 25.
10
Measurement in clinical trials: a neglected issue for statisticians?临床试验中的测量:统计学家忽视的问题?
Stat Med. 2009 Nov 20;28(26):3189-209. doi: 10.1002/sim.3603.